The time to offer treatments for COVID-19

Binh Ngo(Keck Hospital of USC), Ivan Fan‐Ngai Hung(Chinese University of Hong Kong), Miroslaw Smogorewski(Keck Hospital of USC), Gino In(Keck Hospital of USC), Marco Confalonieri(Ospedale di Cattinara), Pierre Kory(Aurora St. Luke's Medical Center), Daniel O. Griffin(Rocky Mountain MS Center), Glenn R. Ehresmann(Keck Hospital of USC), April W. Armstrong(University of California, Los Angeles), Joseph Varón(St. Luke's Episcopal Hospital), David Sawcer(Keck Hospital of USC), Neha Nanda(Keck Hospital of USC), Iraldo Bello Rivero(Centro de Ingeniería Genética y Biotecnología), Eivind H. Vinjevoll(Volda University College), José Iglesias(Bionomics (Australia)), Nicolas Peschanski(Centre Hospitalier Universitaire de Rennes), Gilles Hayem(Hôpital Paris Saint-Joseph), Fred R. Sattler(University of Southern California), Rajkumar Dasgupta(Keck Hospital of USC), Maria Carmela Piccirillo(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Paul E. Marik(Genetic Alliance), Preet M. Chaudhary(USC Norris Comprehensive Cancer Center), Raphael Thomadsen(Washington University in St. Louis), Leland Shapiro(Tufts University), Denise Brennan-Rieder, Daniel G. Arkfeld(Keck Hospital of USC), Marc Rendell(Medical Research Foundation), Cristina Mussini(University of Modena and Reggio Emilia), David Peng(Keck Hospital of USC), Stephen Ditmore(New York Times), Diana L. Hanna(University of Southern California), Michael P. Dubé(Indiana University School of Medicine), António Ferreira(Hospital de Santa Cruz), Vito M. Campese(University of the Republic of San Marino), Mika Turkia
Expert Opinion on Investigational Drugs
March 15, 2021
Cited by 32


Related Papers